Reviewed by WANGYATAO·Last reviewed 2026-11-11·Medical disclaimer

In short

PID is treated on clinical grounds, not on waiting for test results. The Chinese guideline sets a low threshold for starting antibiotics, defines who needs admission, and requires partners to be treated at the same time.

What this guide covers: Why it is easy to miss · How the diagnosis is made · Differential diagnosis · Treatment: start early, cover broadly · When surgery is needed

Pelvic inflammatory disease (PID) is an infection of the upper genital tract — the uterus, fallopian tubes and surrounding pelvic structures. It is almost always the result of bacteria travelling upward from the cervix, and it matters because delayed or incomplete treatment is one of the commonest preventable causes of infertility and ectopic pregnancy.

China's 2023-2025 clinical guideline for PID was written to standardise diagnosis and treatment, because the condition is frequently missed in its milder forms and frequently over-treated with the wrong antibiotic spectrum in its more severe forms.

Why it is easy to miss

PID has no single signature symptom. The classic picture is lower abdominal pain with tenderness when the cervix or uterus is moved during examination, often with abnormal discharge and sometimes fever. But many women have mild or intermittent pain, no fever, and a normal-looking cervix. Roughly one in five women with a history of PID will have another episode, and the risk is highest in sexually active women under 35.

How the diagnosis is made

The guideline uses a three-tier structure. The minimum criterion is simply pelvic pain plus cervical motion tenderness, uterine tenderness or adnexal tenderness — and that alone is enough to start treatment in a sexually active woman with no other explanation.

Additional criteria raise the level of certainty: oral temperature above 38.3 degrees Celsius, purulent cervical discharge or excess white cells on a vaginal smear, a raised erythrocyte sedimentation rate or C-reactive protein, and laboratory confirmation of cervical Neisseria gonorrhoeae or Chlamydia trachomatis. Specific criteria — endometrial biopsy showing endometritis, ultrasound or MRI showing a thickened fluid-filled tube or tubo-ovarian abscess, or laparoscopic findings — confirm the diagnosis.

Investigations in practice are nucleic acid amplification testing for gonorrhoea and chlamydia, transvaginal ultrasound, and blood tests. Laparoscopy remains the most accurate diagnostic tool and is both diagnostic and therapeutic when an abscess needs drainage.

Differential diagnosis

Ectopic pregnancy is the diagnosis that must never be missed, so a pregnancy test is part of the workup. Acute appendicitis, ovarian cyst torsion, and endometriosis all enter the differential, and the guideline lists them explicitly.

Treatment: start early, cover broadly

The single most important principle is that treatment should begin within 48 hours of diagnosis. Delaying antibiotics while waiting for swab results is associated with a higher rate of long-term complications.

For outpatient treatment of mild to moderate disease, the recommended regimen is a single intramuscular dose of ceftriaxone plus oral doxycycline for 14 days, with metronidazole added to cover anaerobes. Cefoxitin with probenecid is an alternative.

Severe disease, pregnancy, a tubo-ovarian abscess, or failure to improve on oral therapy all call for admission. Inpatient regimens use intravenous cephalosporins with doxycycline, or clindamycin with gentamicin, stepped down to oral therapy after sustained clinical improvement.

Two details are emphasised throughout: the antibiotic course must cover gonorrhoea, chlamydia and anaerobes simultaneously because mixed infection is the norm; and sexual partners must be examined and treated at the same time, otherwise reinfection is almost inevitable.

When surgery is needed

Surgery is reserved for a tubo-ovarian abscess that does not respond to antibiotics or is larger than about 4 cm, for suspected rupture, and for chronic disease that keeps relapsing. Laparoscopic drainage or removal of the affected tube and ovary is preferred where feasible.

Follow-up and long-term consequences

Clinical review is expected 72 hours after treatment starts, with repeat pathogen testing around two weeks later and fertility assessment at around three months for women who want to conceive. Around one in ten to one in five women with PID develops a pelvic abscess; infertility, chronic pelvic pain and ectopic pregnancy are the lasting consequences the guideline is trying to prevent.

Sources and further reading

One reference to a U.S. government health source (National Institutes of Health or MedlinePlus) for the medical background of this guide. It is context, not a substitute for advice from your treating doctor.

General information for international patients, not medical advice or a diagnosis. Read the medical disclaimer.